Efficacy of Halobetasol 0.01% Tazarotene 0.045% (HP TAZ) Fixed Combination in the Treatment of Moderate Plaque Psoriasis: Indirect Comparison Between Pooled Phase 3 Trials of HP TAZ and Oral Treatment (Apremilast). J of Skin 2019, 3, S30. https://doi.org/10.25251/skin.3.supp.30.